Using Biobanks to Find New Biomarkers for Neurological Disorders
Author Information
Author(s): Miller Joseph S., Rose Michael, Roell Jonathan, Ubhe Samruddhi, Liu Tom, Segal Benjamin M., Bell Erica H.
Primary Institution: The Ohio State University
Hypothesis
Can biobanks improve the identification of biomarkers for neurological disorders?
Conclusion
A well-structured biobank can significantly enhance the discovery of biomarkers for neurological diseases.
Supporting Evidence
- Biobanks are essential for translating research findings into clinical applications.
- Technological advances allow for better insights into CNS diseases using minimal samples.
- Standardized biobanking practices can enhance the quality and reliability of research.
Takeaway
Biobanks are like treasure chests for scientists, helping them find clues about brain diseases faster and better.
Methodology
The review discusses biobanking practices and a rapid pipeline for single-cell sequencing of fresh blood and CSF specimens.
Potential Biases
Variability in specimen quality and data collection methods may introduce bias.
Limitations
Challenges include the high cost of biobanking, limited access to CNS tissues, and the need for standardized protocols.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website